1461048379-b50c2184-0f3c-4e93-a063-70d52e0ac750

1-77. (canceled)
78. A compound of Formula VIII:
wherein:
G is selected from the group consisting of \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014Se\u2014, \u2014CH2\u2014, \u2014CF2\u2014, \u2014CHF\u2014, \u2014C(O)\u2014, \u2014CH(OH)\u2014, \u2014CH(C1-C4 alkyl)-, \u2014CH(C1-C4 alkoxy)-, \u2014C(\u2550CH2)\u2014, \u2014NH\u2014, and \u2014N(C1-C4 alkyl)-, or CH2 linked to any of the preceding groups;
or G is R50-R51 wherein;
R50-R51 together are \u2014C(R52)\u2550C(R52)\u2014 or alternatively R50 and R51 are independently selected from O, S and \u2014CH(R53)\u2014, with the provisos that at least one R50 and R51 is \u2014CH(R53)\u2014, and when one of R50 and R51 is O or S, then R53 is R54;
R54 is hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, fluoromethyl, difluoromethyl, or trifluoromethyl;
R53 is selected from hydrogen, halogen, hydroxyl, mercapto, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio; and
R52 is selected from hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio;
T is selected from the group consisting of (CRa2)k\u2014, \u2014CRb\u2550CRb\u2014(CRa2)n\u2014, (CRa2)n\u2014CRb\u2550CRb\u2014, (CRa2)\u2014CRb\u2550CRb\u2014(CRa2)\u2014, \u2014O(CRb2)(CRa2)n\u2014, \u2014S(CRb2)(CRa2)n\u2014, \u2014N(Rc)(CRb2)(CRa2)n\u2014, \u2014N(Rb)C(O)(CRa2)n\u2014, \u2014(CRa2)mC(Rb)(NRbRc)\u2014, \u2014C(O)(CRa2)m\u2014, (CRa2)mC(O)\u2014, \u2014(CRb2)\u2014O\u2014(CRb2)\u2014(CRa2)p\u2014, \u2014(CRb2)\u2014S\u2014(CRb2)\u2014(CRa2)p\u2014, \u2014(CRb2)\u2014N(Rc)\u2014(CRb2)\u2014(CRa2)p\u2014, \u2014(CRa2)p\u2014(CRb2)\u2014O\u2014(CRb2)\u2014, (CRa2)p\u2014(CRb2)\u2014S\u2014(CRb2)\u2014, \u2014(CRa2)p\u2014(CRb2)\u2014N(Rc)\u2014(CRb2)\u2014 and \u2014(CH2)pC(O)N(Rb)C(Ra2)\u2014;
k is an integer from 0-4;
m is an integer from 0-3;
n is an integer from 0-2;
p is an integer from 0-1;
Each Ra is independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C4 alkyl, halogen, \u2014OH, optionally substituted \u2014O\u2014C1-C4 alkyl, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014S\u2014C1-C4 alkyl, \u2014NRbRc, optionally substituted \u2014C2-C4 alkenyl, and optionally substituted \u2014C2-C4 alkynyl; with the proviso that when one Ra is attached to C through an O, S, or N atom, then the other Ra attached to the same Cis a hydrogen, or attached via a carbon atom;
Each Rb is independently selected from the group consisting of hydrogen and optionally substituted \u2014C1-C4 alkyl;
Each Rc is independently selected from the group consisting of hydrogen and optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014C(O)\u2014C1-C4 alkyl, and \u2014C(O)H;
R1, R2, R6, and R7 are each independently selected from the group consisting of hydrogen, halogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014S\u2014C1-C3 alkyl, optionally substituted \u2014C2-C4 alkenyl, optionally substituted \u2014C2-C4 alkynyl, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014O\u2014C1-C3 alkyl, and cyano; with the proviso that at least one of R1 and R2 is not hydrogen;
R8 and R9 are each independently selected from the group consisting of hydrogen, halogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014S\u2014C1-C3 alkyl, optionally substituted \u2014C2-C4 alkenyl, optionally substituted \u2014C2-C4 alkynyl, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted-O\u2014C1-C3 alkyl, hydroxy, \u2014(CRa2)aryl, \u2014(CRa2)cycloalkyl,

\u2014(CRa2)heterocycloalkyl, \u2014C(O)aryl, \u2014C(O)cycloalkyl, \u2014C(O)heterocycloalkyl, \u2014C(O)alkyl and cyano;
or R6 and T are taken together along with the carbons they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R5 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRi\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom; and X is attached to this ring by a direct bond to a ring carbon, or by \u2014(CRa2)\u2014 or \u2014C(O)\u2014 bonded to a ring carbon or a ring nitrogen;
Ri is selected from the group consisting of hydrogen, \u2014C(O)C1-C4 alkyl, \u2014C1-C4 alkyl, and \u2014C1-C4-aryl; or
R1 and R7 are taken together along with the carbons to which they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R1 and R7 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom;
t is an integer from 3-6;
r and s are integers from 0-5;
R3 and R4 are each independently selected from the group consisting of hydrogen, halogen, \u2014CF3, \u2014OCF3, cyano, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)maryl, optionally substituted \u2014(CRa2)mcycloalkyl, optionally substituted \u2014(CRa2)mheterocycloalkyl, C(Rb)\u2550C(Rb)-aryl, \u2014C(Rb)\u2550C(Rb)-cycloalkyl, \u2014C(Rb)\u2550C(Rb)-heterocycloalkyl, \u2014C\u2261C(aryl), \u2014C\u2261C(cycloalkyl), \u2014C\u2261C(heterocycloalkyl), \u2014ORd, \u2014SRd, \u2014S(\u2550O)Re, \u2014S(\u2550O)2Re, \u2014S(\u2550O)2NRfRg, \u2014C(O)NRfRg, \u2014C(O)ORh, \u2014C(O)Re, \u2014N(Rb)C(O)Re, \u2014N(Rb)C(O)NRfRg, \u2014N(Rb)S(\u2550O)2Re, \u2014N(Rb)S(\u2550O)2NRfRg, and \u2014NRfRg;
Each Rd is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, optionally substituted

\u2014(CRb2)nheterocycloalkyl, and \u2014C(O)NRfRg;
Each Re is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)naryl, optionally substituted \u2014(CRa2)ncycloalkyl, and optionally substituted \u2014(CRa2)nheterocycloalkyl;
Rf and Rg are each independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl, or Rf and Rg may together form an optionally substituted heterocyclic ring of 3-8 atoms containing 0-4 unsaturations, said heterocyclic ring may contain a second heterogroup within the ring selected from the group consisting of O, NRc, and S, wherein said optionally substituted heterocyclic ring may be substituted with 0-4 substituents selected from the group consisting of optionally substituted \u2014C1-C4 alkyl, \u2014ORb, oxo, cyano, \u2014CF3, \u2014CHF2, \u2014CH2F, optionally substituted phenyl, and \u2014C(O)ORh;
Each Rh is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl; or
R3 and R8 are taken together along with the carbon atoms to which they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R8 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom; or
R8 and G are taken together along with the carbon atoms to which they are attached to form an optionally substituted ring comprising \u2014CH\u2550CH\u2014CH\u2550, \u2014N\u2550CH\u2014CH\u2550, \u2014CH\u2550N\u2014CH\u2550 or \u2014CH\u2550CH\u2014N\u2550;
R5 is selected from the group consisting of \u2014OH, optionally substituted \u2014OC1-C6 alkyl, \u2014OC(O)Re, \u2014OC(O)ORh, \u2014NHC(O)ORh, \u2014OC(O)NH(Rh), \u2014F, \u2014NHC(O)Re, \u2014NHS(\u2550O)Re, \u2014NHS(\u2550O)2Re, \u2014NHC(\u2550S)NH(Rh), and \u2014NHC(O)NH(Rh); or
R3 and R5 are taken together along with the carbons they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R5 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom;
X is P(O)(YR11)(Y\u2032R11);
Y and Y\u2032 are each independently selected from the group consisting of \u2014O\u2014, and \u2014NRv\u2014;
when Y and Y\u2032 are both \u2014O\u2014, R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, \u2014C(Rz)2OC(O)NRz2,

\u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy;
when Y and Y\u2032 are both \u2014NRv\u2014, then R11 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014C(O)ORy, \u2014C(Rx)2C(O)ORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-C(O)ORy;
when Y is \u2014O\u2014 and Y\u2032 is NRv, then R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, \u2014C(Rz)2OC(O)NRz2, \u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy; and R11 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014COORy, \u2014C(Rx)2COORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-COORy; or
when Y and Y\u2032 are independently selected from \u2014O\u2014 and \u2014NRv\u2014, then R11 and R11 together form a cyclic group comprising -alkyl-S\u2014S-alkyl-, or together R11 and R11 are the group:
wherein:
V, W, and W\u2032 are independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted aralkyl, heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, optionally substituted 1-alkenyl, and optionally substituted 1-alkynyl; or
together V and Z are connected via an additional 3-5 atoms to form a cyclic group containing 5-7 atoms, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon, substituted with hydrogen, hydroxy, acyloxy, alkylthiocarbonyloxy, alkoxycarbonyloxy, or aryloxycarbonyloxy attached to a carbon atom that is three atoms from both Y groups attached to the phosphorus; or
together V and Z are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and said cyclic group is fused to an aryl group at the beta and gamma position to the Y attached to the phosphorus; or
together V and W are connected via an additional 3 carbon atoms to form an optionally substituted cyclic group containing 6 carbon atoms or carbon substituted by hydrogen and substituted with one substituent selected from the group consisting of hydroxy, acyloxy, alkoxycarbonyloxy, alkylthiocarbonyloxy, and aryloxycarbonyloxy, attached to one of said carbon atoms that is three atoms from a Y attached to the phosphorus; or
together Z and W are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl; or
together W and W\u2032 are connected via an additional 2-5 atoms to form a cyclic group, wherein 0-2 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
Z is selected from the group consisting of \u2014CHRzOH, \u2014CHRzOC(O)Ry, \u2014CHRzOC(S)Ry, \u2014CHRzOC(S)ORy, \u2014CHRzOC(O)SRy, \u2014CHRzOCO2Ry, \u2014ORz, \u2014SRz, \u2014CHRzN3, \u2014CH2aryl, \u2014CH(aryl)OH, \u2014CH(CH\u2550CRz2)OH, \u2014CH(C\u2261CRz)OH, -Rz, \u2014NRz2, \u2014OCORy, \u2014OCO2Ry, \u2014SCORy, \u2014SCO2Ry, \u2014NHCORz, \u2014NHCO2Ry, \u2014CH2NHaryl, \u2014(CH2)q\u2014ORz, and \u2014(CH2)q\u2014SRz;
q is an integer 2 or 3;
Each Rz is selected from the group consisting of Ry and \u2014H;
Each Ry is selected from the group consisting of alkyl, aryl, heterocycloalkyl, and aralkyl;
Each Rx is independently selected from the group consisting of \u2014H, and alkyl, or together Rx and Rx form a cycloalkyl group;
Each Rv is selected from the group consisting of \u2014H, lower alkyl, acyloxyalkyl, alkoxycarbonyloxyalkyl, and lower acyl;
with the provisos that:
a) when G is \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014C(O)\u2014, \u2014NH\u2014 and, T is \u2014(CH2)0-4\u2014 or \u2014C(O)NH(CRb2)\u2014, R1 and R2 are independently chosen from the group consisting of hydrogen, halogen, \u2014C1-C4 alkyl, R8 and R9 are each independently selected from hydrogen, halogen and C1-4alkyl, R6 and R7 are each independently selected from hydrogen, halogen O\u2014C1-3alkyl, hydroxy, cyano and C1-4alkyl, R3 is \u2014C(O)NR25R26, \u2014CH2\u2014NR25R26, \u2014NR25OC(O)R26, \u2014OR27, R28, or
R4 is hydrogen, halogen, cyano or alkyl, and R5 is \u2014OH, R25 and R26 are each independently selected from the group consisting of hydrogen, aryl, heteroaryl, alkyl, cycloalkyl, aralkyl or heteroaralkyl, R27 is aryl, heteroaryl, alkyl, aralkyl, or heteroaralkyl, R28 is aryl, heteroaryl, or cycloalkyl, R29 is hydrogen, aryl, heteroaryl, alkyl, aralkyl, heteroaralkyl, then X is not \u2014P(O)(OH)2, or \u2014P(O)(O-lower alkyl)2;
b) when G is \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014CF2\u2014, \u2014C(O)\u2014, \u2014NH\u2014 and, T is \u2014C(O)NH(CRb2)\u2014, R1 and R2 are independently halogen, cyano, \u2014C1-C4 alkyl, R8 and R9 are each independently selected from hydrogen, halogen and C1-4alkyl, R6 and R7 are each independently selected from hydrogen, halogen O\u2014C1-3alkyl, hydroxy, cyano and C1-4alkyl, R3 is halogen, \u2014C1-C6 alkyl, \u2014C2-C6 alkynyl, \u2014C4-C7 cycloalkenyl, \u2014C3-C7 cycloalkoxy, \u2014S(\u2550O)2(NR14R15), \u2014N(R16)S(\u2550O)2R17, \u2014SR17, \u2014S(\u2550O)R17,

\u2014S(\u2550O)2R17, \u2014C(O)R16, or \u2014CR18(OR16)R19, R4 is halogen, cyano or alkyl, and R5 is \u2014OH, optionally substituted \u2014OC1-C6 alkyl, aroyl or alkanoyl, R14, R15, R16, R18 and R19 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, heteroalkyl, arylalkyl, and heteroarylalkyl, R17 is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroalkyl, arylalkyl, and heteroarylalkyl, or R14 and R15 may be joined so as to comprise a chain of 3 to 6 methylene groups to form a ring of 4 to 7-membered in size, then X is not \u2014P(O)(OH)2 or \u2014P(O)(O-lower alkyl)2;
c) when G is O and T is \u2014(CH2)k\u2014, R1 and R2 are independently halogen, alkyl of 1 to 3 carbons, R3 is alkyl of 1 to 4 carbons or cycloalkyl of 3 to 7 carbons, R4 is hydrogen, R5 is OH, R6, R7, R8 and R9 are hydrogen, then X is not phosphonic acid or a lower alkyl ester thereof;
d) when G is O, T is \u2014(CH2)1-3\u2014 or \u2014(CH2)1-2\u2014CH(Raa), Raa is \u2014OH, \u2014NH2, \u2014NH(C1-4alkyl), \u2014NH(C2-4alkenyl), or \u2014NH(C2-4alkynyl), R4, R6, R7, R8 and R9 are hydrogen, R1 and R2 are independently selected from halogen, C1 alkyl substituted with 1, 2, or 3 hydrogen, fluorine, or a bioisosteric equivalent, C1-4 alkyl and CF3, and R3 and R5 are taken together along with the carbon atoms to which they are attached to form a five member heterocyclic ring of formula -A-C(Rbb)\u2550B\u2014 wherein A, attached where the R5 group is attached, is selected from \u2014O\u2014, \u2014S\u2014, and \u2014NRh\u2014, B is selected from \u2014CH\u2014, and \u2014N\u2014, Rbb is selected from C6-10aryl, C5-9heteroaryl, or C1-4alkyl, then X is not phosphonic acid, phosphamic acid, or a lower alkyl ester or acyloxyalkyl ester thereof;
e) when G is O, R4, R6, R7, R8 and R9 are hydrogen, R3 is selected from hydrogen, halogen, cyano, C6-10aryl, C5-10heteroaryl, C1-10alkyl, C3-8cycloalkyl, C2-alkenyl, C2-10alkynyl, and R5 is \u2014NHC(O)Re, NHS(\u2550O)Re, \u2014NHS(\u2550O)2Re, \u2014NHC(\u2550S)NH(Rh) or \u2014NHC(O)NH(Rh), then X is not phosphonic acid or phosphamic acid or a lower alkyl ester thereof;
f) when G is \u2014CH2\u2014O\u2014, wherein the oxygen atom is attached to the ring bearing the T group, R6 and R7 are hydrogen, T is \u2014(CH2)1-2CH(Rcc), Rcc is \u2014OH, \u2014SH, \u2014NH2, or \u2014NH(C1-4), R1 and R2 are each independently selected from chlorine, bromine, C1-4 alkyl, C2-4 alkenyl, and C2-4 alkynyl, then X is not phosphonic acid or phosphamic acid or a lower alkyl ester thereof;
g) when G is O, T is \u2014(CRa2)0-4\u2014, R4, R6, R7 and R8 are hydrogen, R5 is hydroxy, methoxy, or \u2014NHC(O)Re, R3 is hydrogen, halogen, C1-4alkyl, C3-6cycloalkyl, or C5-8cycloalkylalkyl, R1 and R2 are each independently selected from hydrogen, halogen, C1-4alkyl, or C3-6cycloalkyl, and R9 is C1-4alkyl, CH2aryl, C(O)aryl, or C(O)alkyl, then X is not phosphonic acid or a lower alkyl ester thereof;
h) V, Z, W, W\u2032 are not all \u2014H; and
i) when Z is -Rz, then at least one of V, W, and W\u2032 is not \u2014H, alkyl, aralkyl, or heterocycloalkyl;
and pharmaceutically acceptable salts and prodrugs thereof and pharmaceutically acceptable salts of said prodrugs.
79. The compound of claim 78, having Formula I:
wherein:
G is selected from the group consisting of \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014CF2\u2014, \u2014CHF\u2014, \u2014C(O)\u2014, \u2014CH(OH)\u2014, \u2014NH\u2014, and \u2014N(C1-C4 alkyl)-, or CH2 linked to any of the preceding groups;
or G is R50-R51 wherein;
R50-R51 together are \u2014C(R52)\u2550C(R52)\u2014 or alternatively R50 and R51 are independently selected from O, S and \u2014CH(R53)\u2014, with the provisos that at least one R50 and R51 is \u2014CH(R53)\u2014, and when one of R50 and R51 is O or S, then R53 is R54;
R54 is hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, fluoromethyl, difluoromethyl, or trifluoromethyl;
R53 is selected from hydrogen, halogen, hydroxyl, mercapto, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio; and
R52 is selected from hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio;
T is selected from the group consisting of \u2014(CRa2)k\u2014, \u2014CRb\u2550CRb\u2014(CRa2)n\u2014, \u2014(CRa2)n\u2014CRb\u2550CRb\u2014, \u2014(CRa2)\u2014CRb\u2550CRb\u2014(CRa2)\u2014, O(CRb2)(CRa2)n\u2014, \u2014S(CRb2)(CRa2)n\u2014, \u2014N(Rc)(CRb2)(CRa2)n\u2014, \u2014N(Rb)C(O)(CRa2)n\u2014, \u2014(CRa2)mC(Rb)(NRbRc)\u2014, \u2014C(O)(CRa2)m\u2014, \u2014(CRa2)mC(O)\u2014, \u2014(CRb2)\u2014O\u2014(CRb2)\u2014(CRa2)m\u2014, \u2014(CRb2)\u2014S\u2014(CRb2)\u2014(CRa2)p\u2014, \u2014(CRb2)\u2014N(Rc)\u2014(CRb2)\u2014(CRa2)p\u2014(CRa2)p\u2014(CRb2)\u2014O\u2014(CRb2)\u2014, (CRa2)p\u2014(CRb2)\u2014S\u2014(CRb2)_\u2014(CRa2)p\u2014(CRb2)\u2014N(R)\u2014(CR2)\u2014 and \u2014(CH2)pC(O)N(Rb)C(Ra2)\u2014;
k is an integer from 0-4;
m is an integer from 0-3;
n is an integer from 0-2;
p is an integer from 0-1;
Each Ra is independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C4 alkyl, halogen, \u2014OH, optionally substituted \u2014O\u2014C1-C4 alkyl, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014S\u2014C1-C4 alkyl, \u2014NRbRc, optionally substituted \u2014C2-C4 alkenyl, and optionally substituted \u2014C2-C4 alkynyl; with the proviso that when one Ra is attached to C through an O, S, or N atom, then the other Ra attached to the same Cis a hydrogen, or attached via a carbon atom;
Each Rb is independently selected from the group consisting of hydrogen and optionally substituted \u2014C1-C4 alkyl;
Each Rc is independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014C(O)\u2014C1-C4 alkyl, and \u2014C(O)H;
R1 and R2 are each independently selected from the group consisting of halogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014S\u2014C1-C3 alkyl, optionally substituted \u2014C2-C4 alkenyl, optionally substituted \u2014C2-C4 alkynyl, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014O\u2014C1-C3 alkyl, and cyano;
R3 and R4 are each independently selected from the group consisting of hydrogen, halogen, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, cyano, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)naryl, optionally substituted \u2014(CRa2)mcycloalkyl, optionally substituted (CRa2)mheterocycloalkyl, \u2014C(Rb)\u2550C(Rb)-aryl, \u2014C(Rb)\u2550C(Rb)-cycloalkyl, \u2014C(Rb)\u2550C(Rb)-heterocycloalkyl, \u2014C\u2261C(aryl), \u2014C\u2261C(cycloalkyl), \u2014C\u2261C(heterocycloalkyl), \u2014(CRa2)n(CRb2)NRfRg, \u2014ORd, \u2014S(\u2550O)Re, \u2014S(\u2550O)2Re, \u2014S(\u2550O)2NRfRg, \u2014C(O)NRfRg, \u2014C(O)ORh, \u2014C(O)Re, \u2014N(Rb)C(O)Rc, \u2014N(Rb)C(O)NRfRg, \u2014N(Rb)S(\u2550O)2Re, \u2014N(Rb)S(\u2550O)2NRfRg, and \u2014NRfRg;
Each Rd is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, optionally substituted

\u2014(CRb2)nheterocycloalkyl, and \u2014C(O)NRfRg;
Each Re is optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)naryl, optionally substituted \u2014(CRa2)ncycloalkyl, and optionally substituted \u2014(CRa2)nheterocycloalkyl;
Rf and Rg are each independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl, or Rf and Rg may together form an optionally substituted heterocyclic ring of 3-8 atoms containing 0-4 unsaturations, which may contain a second heterogroup selected from the group of O, NRc, and S, wherein said optionally substituted heterocyclic ring may be substituted with 0-4 substituents selected from the group consisting of optionally substituted \u2014C1-C4 alkyl, \u2014ORb, oxo, cyano, \u2014CF3, \u2014CHF2, \u2014CH2F, optionally substituted phenyl, and \u2014C(O)ORh;
Each Rh is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl;
R5 is selected from the group consisting of \u2014OH, optionally substituted \u2014OC1-C6 alkyl, \u2014OC(O)Re, \u2014OC(O)ORh, \u2014NHC(O)ORh, \u2014OC(O)NH(Rh), \u2014F, \u2014NHC(O)Re, \u2014NHS(\u2550O)Re, \u2014NHS(\u2550O)2Re, \u2014NHC(\u2550S)NH(Rh), and \u2014NHC(O)NH(Rh); or
R3 and R5 are taken together along with the carbons they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R5 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom;
X is P(O)(YR11)(Y\u2032R11);
Y and Y\u2032 are each independently selected from the group consisting of \u2014O\u2014, and NRv\u2014;
when Y and Y\u2032 are both \u2014O\u2014, R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, \u2014C(Rz)2OC(O)NRz2, \u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy; and
when Y and Y\u2032 are both \u2014NRv\u2014, then R11 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014C(O)ORy, \u2014C(Rx)2C(O)ORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-C(O)ORy; and
when Y is \u2014O\u2014 and Y\u2032 is NRv, then R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, \u2014C(Rz)2OC(O)NRz2,

\u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy; and R11 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014COORy, \u2014C(Rx)2COORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-COORy;
or when Y and Y\u2032 are independently selected from \u2014O\u2014 and \u2014NRv\u2014, then R11 and R11 together form a cyclic group comprising -alkyl-S\u2014S-alkyl-, or R11 and R11 together are the group:
wherein:
V, W, and W\u2032 are independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted aralkyl, heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, optionally substituted 1-alkenyl, and optionally substituted 1-alkynyl;
or together V and Z are connected via an additional 3-5 atoms to form a cyclic group containing 5-7 atoms, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon, substituted with hydrogen, hydroxy, acyloxy, alkylthiocarbonyloxy, alkoxycarbonyloxy, or aryloxycarbonyloxy attached to a carbon atom that is three atoms from both Y groups attached to the phosphorus; or
or together V and Z are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and said cyclic group is fused to an aryl group at the beta and gamma position to the Y attached to the phosphorus;
or together V and W are connected via an additional 3 carbon atoms to form an optionally substituted cyclic group containing 6 carbon atoms or carbon substituted by hydrogen and substituted with one substituent selected from the group consisting of hydroxy, acyloxy, alkoxycarbonyloxy, alkylthiocarbonyloxy, and aryloxycarbonyloxy, attached to one of said carbon atoms that is three atoms from a Y attached to the phosphorus;
or together Z and W are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
or together W and W\u2032 are connected via an additional 2-5 atoms to form a cyclic group, wherein O2 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
Z is selected from the group consisting of \u2014CHRzOH, \u2014CHRzOC(O)Ry, \u2014CHRzOC(S)Ry, \u2014CHRzOC(S)ORy, \u2014CHRzOC(O)SRy, \u2014CHRzOCO2Ry, \u2014ORz, \u2014SRz, \u2014CHRzN3, \u2014CH2aryl, \u2014CH(aryl)OH, \u2014CH(CH\u2550CRz2)OH, \u2014CH(C\u2261CRz)OH, -Rz, \u2014NRz2, \u2014OCORy, \u2014OCO2Ry, \u2014SCORy, \u2014SCO2Ry, \u2014NHCORz, \u2014NHCO2Ry, \u2014CH2NHaryl, \u2014(CH2)q\u2014ORz, and \u2014(CH2)q\u2014SRz;
q is an integer 2 or 3;
Each Rz is selected from the group consisting of Ry and \u2014H;
Each Ry is selected from the group consisting of alkyl, aryl, heterocycloalkyl, and aralkyl;
Each Rx is independently selected from the group consisting of \u2014H, and alkyl, or together Rx and Rx form a cycloalkyl group;
Each Rv is selected from the group consisting of \u2014H, lower alkyl, acyloxyalkyl, alkoxycarbonyloxyalkyl, and lower acyl;
with the provisos that:
a) when G is \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014C(O)\u2014, \u2014NH\u2014 and, T is \u2014(CH2)04\u2014 or \u2014C(O)NH(CRb2)\u2014, R1 and R2 are independently chosen from the group consisting of hydrogen, halogen, \u2014C1-C4 alkyl, R3 is C(O)NR25R26, \u2014CH2\u2014NR25R26, \u2014NR25\u2014C(O)R26, \u2014OR27, R28, or
R4 is hydrogen, halogen, cyano or alkyl, and R5 is \u2014OH, R25 and R26 are each independently selected from the group consisting of hydrogen, aryl, heteroaryl, alkyl, cycloalkyl, aralkyl or heteroaralkyl, R27 is aryl, heteroaryl, alkyl, aralkyl, or heteroaralkyl, R28 is aryl, heteroaryl, or cycloalkyl, R29 is hydrogen, aryl, heteroaryl, alkyl, aralkyl, heteroaralkyl, then X is not \u2014P(O)(OH)2, or \u2014P(O)(O-lower alkyl)2;
b) when G is \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014CF2\u2014, \u2014C(O)\u2014, \u2014NH\u2014 and, T is \u2014C(O)NH(CRb2)\u2014, R1 and R2 are independently halogen, cyano, \u2014C1-C4 alkyl, R3 is halogen, \u2014C1-C6 alkyl, \u2014C2-C6 alkynyl, \u2014C4-C7 cycloalkenyl, \u2014C3-C7 cycloalkoxy, \u2014S(\u2550O)2(NR14R15), \u2014N(R16)S(\u2550O)2R17, \u2014SR17, \u2014S(\u2550O)R17, \u2014S(\u2550O)2R17, \u2014C(O)R16, or \u2014CR18(OR16)R19, R4 is halogen, cyano or alkyl, and R5 is \u2014OH, optionally substituted \u2014OC1-C6 alkyl, aroyl or alkanoyl, R14, R15, R16, R18 and R19 are independently selected from the group consisting of hydrogen, alkyl, cycloalkyl, aryl, heteroalkyl, arylalkyl, and heteroarylalkyl, or R14 and R15 may be joined so as to comprise a chain of 3 to 6 methylene groups to form a ring of 4 to 7-membered in size, R17 is selected from the group consisting of alkyl, cycloalkyl, aryl, heteroalkyl, arylalkyl, and heteroarylalkyl, then X is not \u2014P(O)(OH)2 or \u2014P(O)(O-lower alkyl)2;
c) when G is O and T is \u2014(CH2)k\u2014, R1 and R2 are independently halogen, alkyl of 1 to 3 carbons, R3 is alkyl of 1 to 4 carbons or cycloalkyl of 3 to 7 carbons, R4 is hydrogen, R5 is OH, then X is not phosphonic acid or a lower alkyl ester thereof;
d) when G is O, T is \u2014(CH2)1-3\u2014 or \u2014(CH2)1-2\u2014CH(Raa), Raa is \u2014OH, \u2014NH2, \u2014NH(C1-4alkyl), \u2014NH(C2-4alkenyl), or \u2014NH(C2-4alkynyl), R4 is hydrogen, R1 and R2 are independently selected from halogen, C1 alkyl substituted with 1, 2, or 3 hydrogen, fluorine, or a bioisosteric equivalent, C1-4 alkyl and CF3, and R3 and R5 are taken together along with the carbon atoms to which they are attached to form a five member heterocyclic ring of formula -A-C(Rbb)\u2550B\u2014 wherein A, attached where the R5 group is attached, is selected from \u2014O\u2014, \u2014S\u2014, and \u2014NRh\u2014, B is selected from \u2014CH\u2014, and \u2014N\u2014, Rbb is selected from C6-10aryl, C5-9heteroaryl, or C1-4alkyl, then X is not phosphonic acid, phosphamic acid, or a lower alkyl ester or acyloxyalkyl ester thereof;
e) when G is O, R4 is hydrogen, R3 is selected from hydrogen, halogen, cyano, C6-10aryl, C5-10heteroaryl, C1-10alkyl, C3-8cycloalkyl, C2-10alkenyl, C2-10alkynyl, and R5 is \u2014NHC(O)Re, \u2014NHS(\u2550O)Re, \u2014NHS(\u2550O)2Re, \u2014NHC(\u2550S)NH(Rh) or \u2014NHC(O)NH(Rh), T is \u2014(CH2)1-2\u2014, \u2014CH\u2550CH\u2014, \u2014O(CH2)1-2\u2014, or \u2014NH(CH2)1-2\u2014, then X is not phosphonic acid or phosphamic acid or a lower alkyl ester thereof;
f) when G is \u2014CH2\u2014O\u2014, wherein the oxygen atom is attached to the ring bearing the T group, T is \u2014(CH2)1-2CH(Rcc), Rcc is \u2014OH, \u2014SH, \u2014NH2, or \u2014NH(Cl4), R1 and R2 are each independently selected from chlorine, bromine, C1-4 alkyl, C2-4 alkenyl, and C2-4 alkynyl, then X is not phosphonic acid or phosphamic acid or a lower alkyl ester thereof;
g) V, Z, W, W\u2032 are not all \u2014H; and
h) when Z is -Rz, then at least one of V, W, and W\u2032 is not \u2014H, alkyl, aralkyl, or heterocycloalkyl;
and pharmaceutically acceptable salts and prodrugs thereof and pharmaceutically acceptable salts of said prodrugs.
80. A compound of Formula III:
wherein:
G is selected from the group consisting of \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014CF2\u2014, \u2014CHF\u2014, \u2014C(O)\u2014, \u2014CH(OH)\u2014, \u2014NH\u2014, and \u2014N(C1-C4 alkyl)-, or CH2 linked to any of the preceding groups;
or G is R50-R51 wherein;
R50-R51 together are \u2014C(R52)\u2550C(R2)\u2014 or alternatively R50 and R51 are independently selected from O, S and \u2014CH(R53)\u2014, with the provisos that at least one R50 and R51 is CH(R53)\u2014, and when one of R50 and R51 is O or S, then R53 is R54;

R54 is hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, fluoromethyl, difluoromethyl, or trifluoromethyl;
R53 is selected from hydrogen, halogen, hydroxyl, mercapto, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio; and
R52 is selected from hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio;
T is selected from the group consisting of (CRa2)k\u2014, \u2014CRb\u2550CRb\u2014(CRa2)\u2014CRa2)nCRb\u2550CRb\u2014, \u2014(CRa2)\u2014CRb\u2550CRb\u2014(CRa2)\u2014, \u2014O(CRb2)(CRa2)n\u2014, \u2014S(CRb2)(CRa2)n\u2014, \u2014N(Rc)(CRb2)(CRa2)n\u2014, \u2014N(Rb)C(O)(CRa2)n, (CRa2)mC(Rb)(NRbRc)\u2014, \u2014C(O)(CRa2)m, \u2014(CRa2)mC(O)\u2014, \u2014(CRb2)\u2014O\u2014(CRb2)\u2014(CRa2)p\u2014, \u2014(CRb2)\u2014S\u2014(CRb2)\u2014(CRa2)p\u2014, \u2014(CRb2)\u2014N(Rc)\u2014(CRb2)\u2014(CRa2)p\u2014, \u2014(CRa2)p\u2014(CRb2)\u2014O\u2014(CRb2)\u2014, \u2014(CRa2)p\u2014(CRb2)\u2014S\u2014(CRb2)\u2014, \u2014(CRa2)p\u2014(CRb2)\u2014N(Re)\u2014(CR2)\u2014 and \u2014(CH2)pC(O)N(Rb)C(Ra2)\u2014;
k is an integer from 0-4;
m is an integer from 0-3;
n is an integer from 0-2;
p is an integer from 0-1;
Each Ra is independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C4 alkyl, halogen, \u2014OH, optionally substituted \u2014O\u2014C1-C4 alkyl, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014S\u2014C1-C4 alkyl, \u2014NRbRc, optionally substituted \u2014C2-C4 alkenyl, and optionally substituted \u2014C2-C4 alkynyl; with the proviso that when one Ra is attached to C through an O, S, or N atom, then the other Ra attached to the same Cis a hydrogen, or attached via a carbon atom;
Each Rb is independently selected from the group consisting of hydrogen and optionally substituted \u2014C1-C4 alkyl;
Each Rc is independently selected from the group consisting of hydrogen and optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014C(O)\u2014C1-C4 alkyl, and \u2014C(O)H;
R1 and R2 are each independently selected from the group consisting of halogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014S\u2014C1-C3 alkyl, optionally substituted \u2014C2-C4 alkenyl, optionally substituted \u2014C2-C4 alkynyl, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014O\u2014C1-C3 alkyl, and cyano;
R8 is selected from the group consisting of hydrogen, halogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014S\u2014C1-C3 alkyl, optionally substituted \u2014C2-C4 alkenyl, optionally substituted \u2014C2-C4 alkynyl, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014O\u2014C1-C3 alkyl, hydroxy, \u2014(CRa2)aryl, \u2014(CRa2)cycloalkyl,

\u2014(CRa2)heterocycloalkyl, \u2014C(O)aryl, \u2014C(O)cycloalkyl, \u2014C(O)heterocycloalkyl, \u2014C(O)alkyl and cyano;
R3 and R4 are each independently selected from the group consisting of hydrogen, halogen, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, cyano, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)maryl, optionally substituted \u2014(CRa2)ncycloalkyl, optionally substituted \u2014(CRa2)mheterocycloalkyl, \u2014C(Rb)\u2550C(Rb)-aryl, \u2014C(Rb)\u2550C(Rb)_cycloalkyl, \u2014C(Rb)\u2550C(Rb)-heterocycloalkyl, \u2014C\u2261C(aryl), \u2014C\u2261C(cycloalkyl), \u2014C\u2261C(heterocycloalkyl), \u2014(CRa2)n(CRb2)NRfRg, \u2014ORd, \u2014SRd, \u2014S(\u2550O)Re, \u2014S(\u2550O)2Re, \u2014S(\u2550O)2NRfRg, \u2014C(O)NRfRg, \u2014C(O)ORh, \u2014C(O)Re, \u2014N(Rb)C(O)Re, \u2014N(Rb)C(O)NRfRg, \u2014N(Rb)S(\u2550O)2Re, \u2014N(Rb)S(\u2550O)2NRfRg, and \u2014NRfRg;
Each Rd is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, optionally substituted \u2014(CRb2)nheterocycloalkyl, and \u2014C(O)NRfRg;
Each Re is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)naryl, optionally substituted \u2014(CRa2)ncycloalkyl, and optionally substituted \u2014(CRa2)nheterocycloalkyl;
Rf and Rg are each independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl, or Rf and Rg may together form an optionally substituted heterocyclic ring of 3-8 atoms containing 0-4 unsaturations, which may contain a second heterogroup selected from the group consisting of O, NRc, and S, wherein said optionally substituted heterocyclic ring may be substituted with 0-4 substituents selected from the group consisting of optionally substituted \u2014C1-C4 alkyl, \u2014ORb, oxo, cyano, \u2014CF3, \u2014CHF2, \u2014CH2F, optionally substituted phenyl, and \u2014C(O)ORh;
Each Rh is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl; or
R3 and R8 are taken together along with the carbon atoms to which they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R8 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom; or
R8 and G are taken together along with the carbon atoms to which they are attached to form an optionally substituted ring comprising \u2014CH\u2550CH\u2014CH\u2550, \u2014N\u2550CH\u2014CH\u2550, \u2014CH\u2550N\u2014CH\u2550 or \u2014CH\u2550CH\u2014N\u2550;
R5 is selected from the group consisting of \u2014OH, optionally substituted \u2014OC1-C6 alkyl, \u2014OC(O)Re, \u2014OC(O)ORh, \u2014NHC(O)ORh, \u2014OC(O)NH(Rh), \u2014F, \u2014NHC(O)Re, \u2014NHS(\u2550O)Re, \u2014NHS(\u2550O)2Re, \u2014NHC(\u2550S)NH(Rh), and \u2014NHC(O)NH(Rh); or
R3 and R5 are taken together along with the carbons they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R5 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom;
R7 is selected from the group consisting of hydrogen, halogen, amino, hydroxyl, \u2014O\u2014C1-C4 alkyl, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, \u2014CF3, \u2014CHF2, \u2014CH2F, cyano, \u2014SH and \u2014S-C1-C4 alkyl;
X is P(O)(YR11)(Y\u2032R11);
Y and Y\u2032 are each independently selected from the group consisting of \u2014O\u2014, and NRv\u2014;
when Y and Y\u2032 are both \u2014O\u2014, R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, \u2014C(Rz)2OC(O)NRz2, \u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy;
when Y and Y\u2032 are both \u2014NRv\u2014, then R11 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014C(O)ORy, \u2014C(Rx)2C(O)ORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-C(O)ORy;
when Y is \u2014O\u2014 and Y11 is NRv, then R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, C(Rz)2OC(O)NRz2, \u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy; and R11 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014COORy, \u2014C(Rx)2COORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-COORy;
or when Y and Y\u2032 are independently selected from \u2014O\u2014 and \u2014NRv\u2014, then R11 and R11 together form a cyclic group comprising -alkyl-S\u2014S-alkyl-, or together R11 and R11 are the group:
wherein:
V, W, and W\u2032 are independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted aralkyl, heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, optionally substituted 1-alkenyl, and optionally substituted 1-alkynyl; or
together V and Z are connected via an additional 3-5 atoms to form a cyclic group containing 5-7 atoms, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon, substituted with hydrogen, hydroxy, acyloxy, alkylthiocarbonyloxy, alkoxycarbonyloxy, or aryloxycarbonyloxy attached to a carbon atom that is three atoms from both Y groups attached to the phosphorus; or
together V and Z are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and said cyclic group is fused to an aryl group at the beta and gamma position to the Y attached to the phosphorus; or
together V and W are connected via an additional 3 carbon atoms to form an optionally substituted cyclic group containing 6 carbon atoms or carbon substituted by hydrogen and substituted with one substituent selected from the group consisting of hydroxy, acyloxy, alkoxycarbonyloxy, alkylthiocarbonyloxy, and aryloxycarbonyloxy, attached to one of said carbon atoms that is three atoms from a Y attached to the phosphorus; or
together Z and W are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
or together W and W\u2032 are connected via an additional 2-5 atoms to form a cyclic group, wherein 0-2 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
Z is selected from the group consisting of \u2014CHRzOH, \u2014CHRzOC(O)Ry, \u2014CHRzOC(S)Ry, \u2014CHRzOC(S)ORy, \u2014CHRzOC(O)SRy, \u2014CHRzOCO2Ry, \u2014ORz, \u2014SRz, \u2014CHRzN3, \u2014CH2aryl, \u2014CH(aryl)OH, \u2014CH(CH\u2550CRz2)OH, \u2014CH(C\u2261CRz)OH, -Rz, \u2014NRz2, \u2014OCORy, \u2014OCO2Ry, \u2014SCORy, \u2014SCO2Ry, \u2014NHCORz, \u2014NHCO2Ry, \u2014CH2NHaryl, \u2014(CH2)q\u2014ORz, and \u2014(CH2)q\u2014SRz;
q is an integer 2 or 3;
Each Rz is selected from the group consisting of Ry and \u2014H;
Each Ry is selected from the group consisting of alkyl, aryl, heterocycloalkyl, and aralkyl;
Each Rx is independently selected from the group consisting of \u2014H, and alkyl, or together Rx and Rx form a cycloalkyl group;
Each Rv is selected from the group consisting of \u2014H, lower alkyl, acyloxyalkyl, alkoxycarbonyloxyalkyl, and lower acyl;
with the provisos that:
a) when G is selected from the group consisting of \u2014O\u2014, \u2014S\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014CH(OH)\u2014, \u2014C(O)\u2014 and \u2014NRb\u2014; T is -A-B- where A is selected from the group consisting of \u2014NRb\u2014, \u2014O\u2014, \u2014CH2\u2014 and \u2014S\u2014 and B is selected from the group consisting of a bond and substituted or unsubstituted C1-C3 alkyl; R3 is selected from the group consisting of halogen, trifluoromethyl, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted aryl, substituted or unsubstituted heteroaryl, aryloxy, substituted amide, sulfone, sulfonamide and C3-C7 cycloalkyl, wherein said aryl, heteroaryl or cycloalkyl ring(s) are attached or fused to the aromatic; R4 is selected from the group consisting of hydrogen, halogen, substituted or unsubstituted C1-C6 alkyl, substituted or unsubstituted aryl, and substituted or unsubstituted heteroaryl; R1 and R2 are each independently selected from the group consisting of halogen, and substituted or unsubstituted C1-C4 alkyl; R7 is selected from the group consisting of hydrogen, halogen, amino, hydroxyl, \u2014C1-C4 alkyl, \u2014O\u2014C1-C4 alkyl, \u2014SH and \u2014S\u2014C1-C4 alkyl; and R5 is selected from the group consisting of hydroxyl, optionally substituted \u2014OC1-C6 alkyl, and \u2014OC(O)Re; then X is not \u2014P(O)(OH)2 or a lower alkyl ester or acyloxyalkyl ester thereof;
b) V, Z, W, W\u2032 are not all \u2014H; and
c) when Z is -Rz, then at least one of V, W, and W\u2032 is not \u2014H, alkyl, aralkyl, or heterocycloalkyl;
and pharmaceutically acceptable salts and prodrugs thereof and pharmaceutically acceptable salts of said prodrugs.
81. The compound of claim 78 having Formula II:
wherein:
A is selected from the group consisting of \u2014NRi\u2014, \u2014O\u2014, and \u2014S\u2014;
B is selected from the group consisting of \u2014CRb\u2014, and \u2014N\u2014;
Ri is selected from the group consisting of hydrogen, \u2014C(O)C1-C4 alkyl, and \u2014C1-C4 alkyl;
Rb is selected from the group consisting of hydrogen and optionally substituted \u2014C1-C4 alkyl;
G is selected from the group consisting of \u2014O\u2014, \u2014S\u2014, \u2014Se\u2014, \u2014S(\u2550O)\u2014, \u2014S(\u2550O)2\u2014, \u2014CH2\u2014, \u2014CF2\u2014, \u2014CHF\u2014, \u2014C(O)\u2014, \u2014CH(OH)\u2014, \u2014NH\u2014, and \u2014N(C1-C4 alkyl)-, or CH2 linked to any of the preceding groups;
or G is R50-R51 wherein;
R50-R51 together are -(R52)\u2550C(R52)\u2014 or alternatively R50 and R51 are independently selected from O, S and \u2014CH(R53)\u2014, with the provisos that at least one R50 and R51 is \u2014CH(R53)\u2014, and when one of R50 and R51 is O or S, then R53 is R54;
R54 is hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, fluoromethyl, difluoromethyl, or trifluoromethyl;
R53 is selected from hydrogen, halogen, hydroxyl, mercapto, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio; and
R52 is selected from hydrogen, halogen, C1-C4 alkyl, C2-C4 alkenyl, C2-C4 alkynyl, C1-C4 alkoxy, fluoromethyl, difluoromethyl, trifluoromethyl, fluoromethoxy, difluoromethoxy, trifluoromethoxy, methylthio, fluoromethylthio, difluoromethylthio and trifluoromethylthio;
D is selected from the group consisting of a bond, \u2014(CRa2)\u2014, and \u2014C(O)\u2014;
Each Ra is independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C4 alkyl, halogen, \u2014OH, optionally substituted \u2014O\u2014C1-C4 alkyl, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014S\u2014C1-C4 alkyl, \u2014NRbRc, optionally substituted \u2014C2-C4 alkenyl, and optionally substituted \u2014C2-C4 alkynyl; with the proviso that when one Ra is attached to C through an O, S, or N atom, then the other Ra attached to the same Cis a hydrogen, or attached via a carbon atom;
R1 and R2 are each independently selected from the group consisting of halogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014S\u2014C1-C3 alkyl, optionally substituted \u2014C2-C4 alkenyl, optionally substituted \u2014C2-C4 alkynyl, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014O\u2014C1-C3 alkyl, and cyano; R8 is selected from the group consisting of hydrogen, halogen, optionally substituted \u2014C1-C4 alkyl, optionally substituted \u2014S\u2014C1-C3 alkyl, optionally substituted \u2014C2-C4 alkenyl, optionally substituted \u2014C2-C4 alkynyl, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, optionally substituted \u2014O\u2014C1-C3 alkyl, hydroxy, \u2014(CRa2)aryl, \u2014(CRa2)cycloalkyl, \u2014(CRa2)heterocycloalkyl, \u2014C(O)aryl, \u2014C(O)cycloalkyl, \u2014C(O)heterocycloalkyl, \u2014C(O)alkyl and cyano;
R3 and R4 are each independently selected from the group consisting of hydrogen, halogen, \u2014CF3, \u2014CHF2, \u2014CH2F, \u2014OCF3, \u2014OCHF2, \u2014OCH2F, cyano, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)maryl, optionally substituted \u2014(CRa2)ncycloalkyl, optionally substituted \u2014(CRa2)nheterocycloalkyl, \u2014C(Rb)\u2550C(Rb)-aryl, \u2014C(Rb)\u2550C(Rb)_cycloalkyl, \u2014C(kb)\u2550C(Rb)-heterocycloalkyl, \u2014C\u2261C(aryl), \u2014C\u2261C(cycloalkyl), \u2014C\u2261C(heterocycloalkyl), \u2014(CR2)n(CRb2)NRfRg, \u2014ORd, SRd, S(\u2550O)Re, \u2014S(\u2550O)2Re\u2014S(\u2550O)2NRfRg, \u2014C(O)NRfRg, \u2014C(O)ORh, \u2014C(O)Re, \u2014N(Rb)C(O)Re, \u2014N(Rb)C(O)NRfRg, \u2014N(Rb)S(\u2550O)2Re, \u2014N(Rb)S(\u2550O)2NRfRg, and \u2014NRfRg;
Each Rd is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, optionally substituted \u2014(CRb2)nheterocycloalkyl, and \u2014C(O)NRfRg;
Each Rc is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRa2)naryl, optionally substituted \u2014(CRa2)ncycloalkyl, and optionally substituted \u2014(CRa2)nheterocycloalkyl;
Rf and Rg are each independently selected from the group consisting of hydrogen, optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl, or Rf and Rg may together form an optionally substituted heterocyclic ring of 3-8 atoms containing 0-4 unsaturations, which may contain a second heterogroup selected from the group consisting of O, NRc, and S, wherein said optionally substituted heterocyclic ring may be substituted with 0-4 substituents selected from the group consisting of optionally substituted \u2014C1-C4 alkyl, \u2014ORb, oxo, cyano, \u2014CF3, \u2014CHF2, \u2014CH2F, optionally substituted phenyl, and \u2014C(O)ORh;
Each Rh is selected from the group consisting of optionally substituted \u2014C1-C12 alkyl, optionally substituted \u2014C2-C12 alkenyl, optionally substituted \u2014C2-C12 alkynyl, optionally substituted \u2014(CRb2)naryl, optionally substituted \u2014(CRb2)ncycloalkyl, and optionally substituted \u2014(CRb2)nheterocycloalkyl; or
R3 and R8 are taken together along with the carbon atoms to which they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R8 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom; or
R8 and G are taken together along with the carbon atoms to which they are attached to form an optionally substituted ring comprising \u2014CH\u2550CH\u2014CH\u2550, \u2014N\u2550CH\u2014CH\u2550, \u2014CH\u2550N\u2014CH\u2550 or \u2014CH\u2550CH\u2014N\u2550;
R5 is selected from the group consisting of \u2014OH, optionally substituted \u2014OC1-C6 alkyl, \u2014OC(O)Re, \u2014OC(O)ORh, \u2014NHC(O)ORh, \u2014OC(O)NH(Rh), \u2014F, \u2014NHC(O)Re, \u2014NHS(\u2550O)Re, \u2014NHS(\u2550O)2Re, \u2014NHC(\u2550S)NH(Rh), and \u2014NHC(O)NH(Rh); or
R3 and R5 are taken together along with the carbons they are attached to form an optionally substituted ring of 5 to 6 atoms with 0-2 unsaturations, not including the unsaturation on the ring to which R3 and R5 are attached, including 0 to 2 heteroatoms independently selected from \u2014NRh\u2014, \u2014O\u2014, and \u2014S\u2014, with the proviso that when there are 2 heteroatoms in the ring and both heteroatoms are different than nitrogen then both heteroatoms have to be separated by at least one carbon atom;
X is P(O)YR11Y\u2032R11;
Y and Y\u2032 are each independently selected from the group consisting of \u2014O\u2014, and \u2014NRv\u2014;
when Y and Y\u2032 are both \u2014O\u2014, R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, C(Rz)2OC(O)NRz2,

\u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy;
when Y and Y\u2032 are both \u2014NRv\u2014, then R\u2033 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014C(O)ORy, \u2014C(Rx)2C(O)ORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-C(O)ORy;
when Y is \u2014O\u2014 and Y\u2032 is NRv, then R11 attached to \u2014O\u2014 is independently selected from the group consisting of \u2014H, alkyl, optionally substituted aryl, optionally substituted heterocycloalkyl, optionally substituted CH2-heterocycloakyl wherein the cyclic moiety contains a carbonate or thiocarbonate, optionally substituted -alkylaryl, \u2014C(Rz)2OC(O)NRz2, \u2014NRz\u2014C(O)\u2014Ry, \u2014C(Rz)2\u2014OC(O)Ry, \u2014C(Rz)2\u2014O\u2014C(O)ORy, \u2014C(Rz)2OC(O)SRy, -alkyl-S\u2014C(O)Ry, -alkyl-S\u2014S-alkylhydroxy, and -alkyl-S\u2014S\u2014S-alkylhydroxy; and R11 attached to \u2014NRv\u2014 is independently selected from the group consisting of \u2014H, \u2014C(Rz)2q\u2014COORy, \u2014C(Rx)2COORy, \u2014C(Rz)2q\u2014C(O)SRy, and -cycloalkylene-COORy;
or when Y and Y\u2032 are independently selected from \u2014O\u2014 and \u2014NRv\u2014, then R11 and R11 together form a cyclic group comprising -alkyl-S\u2014S-alkyl-, or together R11 and R11 are the group:
wherein:
V, W, and W\u2032 are independently selected from the group consisting of hydrogen, optionally substituted alkyl, optionally substituted aralkyl, heterocycloalkyl, aryl, substituted aryl, heteroaryl, substituted heteroaryl, optionally substituted 1-alkenyl, and optionally substituted 1-alkynyl;
or together V and Z are connected via an additional 3-5 atoms to form a cyclic group containing 5-7 atoms, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon, substituted with hydrogen, hydroxy, acyloxy, alkylthiocarbonyloxy, alkoxycarbonyloxy, or aryloxycarbonyloxy attached to a carbon atom that is three atoms from both Y groups attached to the phosphorus; or
or together V and Z are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and said cyclic group is fused to an aryl group at the beta and gamma position to the Y attached to the phosphorus;
or together V and W are connected via an additional 3 carbon atoms to form an optionally substituted cyclic group containing 6 carbon atoms or carbon substituted by hydrogen and substituted with one substituent selected from the group consisting of hydroxy, acyloxy, alkoxycarbonyloxy, alkylthiocarbonyloxy, and aryloxycarbonyloxy, attached to one of said carbon atoms that is three atoms from a Y attached to the phosphorus;
or together Z and W are connected via an additional 3-5 atoms to form a cyclic group, wherein 0-1 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
or together W and W\u2032 are connected via an additional 2-5 atoms to form a cyclic group, wherein 0-2 atoms are heteroatoms and the remaining atoms are carbon or carbon substituted by hydrogen, and V must be aryl, substituted aryl, heteroaryl, or substituted heteroaryl;
Z is selected from the group consisting of \u2014CHRzOH, \u2014CHRzOC(O)Ry, \u2014CHRzOC(S)Ry, \u2014CHRzOC(S)ORy, \u2014CHRzOC(O)SRy, \u2014CHRzOCO2Ry, \u2014ORz, \u2014SRz, \u2014CHRzN3, \u2014CH2aryl, \u2014CH(aryl)OH, \u2014CH(CH\u2550CRz2)OH, \u2014CH(C\u2261CRz)OH, -Rz, \u2014NRz2, \u2014OCORy, \u2014OCO2Ry, \u2014SCORy, \u2014SCO2Ry, \u2014NHCORz, \u2014NHCO2Ry, \u2014CH2NHaryl, \u2014(CH2)q\u2014ORz, and \u2014(CH2)q\u2014SRz;
q is an integer 2 or 3;
Each Rz is selected from the group consisting of Ry and \u2014H;
Each Ry is selected from the group consisting of alkyl, aryl, heterocycloalkyl, and aralkyl;
Each Rx is independently selected from the group consisting of \u2014H, and alkyl, or together Rx and Rx form a cycloalkyl group;
Each Rv is selected from the group consisting of \u2014H, lower alkyl, acyloxyalkyl, alkoxycarbonyloxyalkyl, and lower acyl;
with the provisos that:
a) V, Z, W, W\u2032 are not all \u2014H; and
b) when Z is -Rz, then at least one of V, W, and W\u2032 is not \u2014H, alkyl, aralkyl, or heterocycloalkyl;
and pharmaceutically acceptable salts and prodrugs thereof and pharmaceutically acceptable salts of said prodrugs.
82. The compound of claim 81 wherein D is selected from the group consisting of a bond and \u2014CH2\u2014.
83. The compound of claim 81 wherein A is selected from the group consisting of \u2014NH\u2014, \u2014NMe-, \u2014O\u2014, and \u2014S\u2014.
84. The compound of claim 81 wherein B is selected from the group consisting of \u2014CH\u2014, \u2014CMe-, and \u2014N\u2014.
85. The compound of claim 80 wherein R7 is selected from the group consisting of hydrogen, fluoro, chloro, amino, hydroxyl, and \u2014O\u2014CH3.
86. The compound of any one of claims 78-81, wherein G is selected from the group consisting of \u2014O\u2014, \u2014CH2\u2014, and R50-R51.
87. The compound of any one of claims 78-80 wherein T is selected from the group consisting of \u2014(CRa2)n\u2014, \u2014O(CRb2)(CRa2)p\u2014, \u2014N(Rc)(CRb2)(CRa2)p\u2014, \u2014S(CRb2)(CRa2)p\u2014, \u2014N(Rb)C(O)\u2014, and \u2014CH2C(Rb)(NRcRb)\u2014.
88. The compound of claim 87 wherein T is \u2014O(CRb2)(CRa2)p\u2014 or \u2014NH(CRb2)(CRa2)p\u2014.
89. The compound of any one of claims 78-81 wherein R1 and R2 are the same and are selected from the group consisting of halogen, \u2014C1-C4 alkyl, \u2014CF3, and cyano.
90. The compound of claim 89 wherein R1 and R2 are both alkyl.
91. The compound of any one of claims 78-81 wherein R1 and R2 are different and are selected from the group consisting of halogen, \u2014C1-C4 alkyl, \u2014CF3, and cyano.
92. The compound of any one of claims 78-81 wherein R4 is selected from the group consisting of hydrogen, halogen, \u2014C1-C4 alkyl, cyano and CF3.
93. The compound of claim 92 wherein R4 is hydrogen.
94. The compound of claim 78 wherein R6 and R7 are independently selected from the group consisting of hydrogen, halogen, \u2014C1-C4 alkyl, cyano and CF3.
95. The compound of claim 94 wherein R6 and R7 are independently hydrogen, halogen, or methyl.
96. The compound of claim 78 wherein R8 and R9 are independently selected from the group consisting of hydrogen, halogen, \u2014C1-C4 alkyl, \u2014C1-C4 alkylaryl, C(O)aryl, cyano and CF3.
97. The compound of claim 96 wherein R8 and R9 are independently hydrogen, halogen, methyl, benzyl, and benzoate.
98. The compound of any one of claims 80-81 wherein R8 is independently selected from the group consisting of hydrogen, halogen, \u2014C1-C4 alkyl, \u2014C1-C4 alkylaryl, C(O)aryl, cyano and CF3.
99. The compound of claim 98 wherein R8 is independently hydrogen, halogen, methyl, benzyl, and benzoate.
100. The compound of any one of claims 78-81 wherein R5 is selected from the group consisting of \u2014OH, \u2014OC(O)Re, \u2014OC(O)ORh, \u2014NHS(O)2Re, and \u2014NHC(O)Rc.
101. The compound of claim 100 wherein R5 is \u2014OH.
102. The compound of any one of claims 78-81 wherein R3 is selected from the group consisting of halogen, optionally substituted \u2014C1-C6 alkyl, \u2014CF3, cyano, \u2014C(O)NRfRg, optionally substituted \u2014(CRa2)naryl, \u2014SO2NRfRg, and \u2014SO2Re.
103. The compound of claim 102 wherein R3 is isopropyl, benzyl or 4-fluorobenzyl.
104. The compound of any one of claims 78-81 wherein X is selected from the group consisting of \u2014PO3H2, \u2014P(O)\u2014OCRz2OC(O)Ry2, \u2014P(O)\u2014OCRz2OC(O)ORy2, \u2014P(O)\u2014N(H)CRz2C(O)ORy2, \u2014P(O)\u2014N(H)CRz2C(O)ORy\u2014OR11, \u2014P(O)\u2014OCH(V) CH2CH2O\u2014, \u2014P(O)(OH)(OR), \u2014P(O)(ORe)(ORe), \u2014P(O) \u2014OCRz2OC(O)Ry(ORe), \u2014P(O) \u2014OCRz2OC(O)ORy(ORe), \u2014P(O)\u2014N(H)CRz2C(O)ORy(ORe), and \u2014P(O)(OH)(NH2) wherein V is selected from the group consisting of optionally substituted aryl, aryl, heteroaryl, and optionally substituted heteroaryl.
105. The compound of any of claims 78-81, wherein X is selected from the group consisting of \u2014PO3H2, \u2014P(O)\u2014OCH2OC(O)-t-butyl2, \u2014P(O)\u2014OCH2OC(O)O-i-propyl2, \u2014P(O)\u2014N(H)CH(CH3)C(O)O CH2CH32, \u2014P(O)\u2014N(H)C(CH3)2C(O)OCH2CH32, \u2014P(O)\u2014N(H)CH (CH3)C(O)OCH2CH33,4-methylenedioxyphenyl, \u2014P(O)\u2014N(H)C (CH3)2C(O)OCH2CH33,4-methylenedioxyphenyl, \u2014P(O) \u2014OCH (3-chlorophenyl)CH2CH2O\u2014, \u2014P(O)\u2014OCH(pyrid-4-yl)CH2CH2O\u2014, \u2014P(O)(OH)(OCH3), \u2014P(O)(OH)(OCH2CH3), \u2014P(O)\u2014OCH2OC(O)-t-butyl(OCH3), \u2014P(O)\u2014OCH2OC(O)O-i-propyl(OCH3), \u2014P(O)\u2014OCH (CH3)OC(O)-t-butyl(OCH3), \u2014P(O)\u2014OCH(CH3)OC(O)O-i-propyl(OCH3), \u2014P(O)\u2014N(H)CH(CH3)C(O)OCH2CH3(OCH3), \u2014P(O)\u2014N(H)C(CH3)2C(O)OCH2CH3(0CH3), \u2014P(O)\u2014N(H)CH2C(O)OCH2CH3(CH3) and \u2014P(O)(OH)(NH2).
106. The compound of any one of claims 78-81 wherein Y and Y\u2032 are each independently selected from \u2014O\u2014 and \u2014NRv\u2014; and together R11 and R11 are the group:
107. The compound of claim 106 wherein V is aryl.
108. The compound of claim 107 wherein Z is hydrogen, W is hydrogen, and W\u2032 is hydrogen.
109. The compound of claim 106 wherein V is selected from the group consisting of 3-chlorophenyl, 4-chlorophenyl, 3-bromophenyl, 3-fluorophenyl, pyrid-4-yl, pyrid-3-yl and 3,5-dichlorophenyl.
110. The compound of claim 109 wherein the relative stereochemistry between the V-group substituent and T on the ring is cis.
111. The compound of claim 110 wherein said cis ring has R stereochemistry at the carbon where the V-group is attached.
112. The compound of claim 111 wherein said cis ring has S stereochemistry at the carbon where the V-group is attached.
113. A compound selected from the group consisting of:
and monomethyl esters thereof, and pharmaceutically acceptable salts and prodrugs of the compounds and monomethyl esters thereof.
114. A compound selected from the group consisting of:
and pharmaceutically acceptable salts thereof.
115. A compound of any one of claims 78-81 wherein said compound is in the form of a co-crystal.
116. A pharmaceutical composition comprising a pharmaceutically effective amount of a compound of any one of claims 78-81.
117. The pharmaceutical composition of claim 116 wherein said pharmaceutical composition in a form selected from the group consisting of a controlled release composition, transdermal patch, tablet, hard capsule, and soft capsule.
118. The pharmaceutical composition of claim 116 wherein said pharmaceutical composition comprises a crystalline form of said compound.
119. The pharmaceutical composition of claim 116 wherein said pharmaceutical composition comprises a salt form of said compound.
120. The pharmaceutical composition of claim 116 wherein said pharmaceutical composition is administered orally in a unit dose of about 0.375 \u03bcgkg to 3.75 mgkg.
121. The pharmaceutical composition of claim 116 wherein said pharmaceutical composition is administered orally in a total daily dose of about 0.375 \u03bcgkgday to about 3.75 mgkgday, equivalent of the free acid.
122. A method of preventing or treating a metabolic disease comprising administering to an animal a pharmaceutically effective amount of a phosphonic acid-containing compound of any one of claims 78-81 and 113-114 or a pharmaceutically acceptable salt thereof, or prodrugs thereof or pharmaceutically acceptable salts of said prodrugs, wherein said phosphonic acid containing compound binds to a thyroid receptor.
123. The method of claim 122 wherein said phosphonic acid containing-compound binds to a thyroid receptor with a Ki of \u22661 \u03bcM.
124. The method of claim 123 wherein said thyroid receptor is TR\u03b11.
125. The method of claim 123 wherein said thyroid receptor is TR\u03b21.
126. The method of claim 124 wherein said phosphonic acid-containing compound binds to a thyroid receptor with a Ki of \u2266100 nM.
127. The method of claim 126 wherein said thyroid receptor is TR\u03b11.
128. The method of claim 126 wherein said thyroid receptor is TR\u03b21.
129. The method of claim 122 wherein said metabolic disease is selected from the group consisting of obesity, hypercholesterolemia, hyperlipidemia, atherosclerosis, coronary heart disease, and hypertension.
130. The method of claim 122 wherein said metabolic disease is selected from the group consisting of obesity, hypercholesterolemia, and hyperlipidemia.
131. The method of claim 130 wherein said metabolic disease is hypercholesterolemia.
132. The method of claim 122 wherein said metabolic disease is fatty liversteatosis, NAFLD, or NASH.
133. The method of claim 122 wherein said metabolic disease is selected from the group consisting of impaired glucose tolerance, diabetes, and metabolic syndrome X.
134. The method of claim 122, wherein said phosphonic acid-containing compound activates said thyroid receptor.
135. The method of claim 134 wherein said thyroid receptor is TR\u03b11.
136. The method of claim 134 wherein said thyroid receptor is TR\u03b11.
137. The method of claim 122 wherein said phosphonic acid containing-compound increases mRNA expression of a gene selected from the group consisting of LDL receptor, ACC, FAS, spot-14, CPT-1, CYP7A, apo AI, and mGPDH.
138. A method of activating a thyroid receptor in an animal by administering a phosphonic acid-containing-compound of any one of claims 78-81 and 113-114 wherein said activation results in the 50% or greater increase in the mRNA expression of a gene selected from the group consisting of LDL receptor, ACC, FAS, spot-14, CPT-1, CYP7A, apo AI, and mGPDH.
139. The method of claim 138 wherein said phosphonic acid-containing-compound binds to a thyroid receptor with a Ki of \u22661 \u03bcM.
140. The method of claim 139 wherein said phosphonic acid-containing-compound binds to a thyroid receptor with a Ki of \u2266100 nM.

The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.

1. A seat belt retractor assembly for a motor vehicle occupant restraint system of the type having a shoulder belt, a lap belt, and a latch plate between the shoulder belt and the lap belt engageable with a buckle, the assembly comprising:
a retractor frame adapted to be mounted to the motor vehicle,
a shoulder belt spool assembly affixed to the frame and connected with the shoulder belt and having a rotatable shoulder belt spool with the shoulder belt wound on the shoulder belt spool for stowing and paying out the shoulder belt,
a lap belt spool assembly affixed to the frame and connected with the lap belt and having a rotatable lap belt spool with the lap belt wound on the lap belt spool for stowing and paying out the lap belt, and
a pretensioner system having a single gas source communicating with a shoulder belt spool pretensioner and a lap belt spool pretensioner, the shoulder belt spool pretensioner coupled to the shoulder belt spool assembly and the lap belt spool pretensioner coupled to the lap belt spool assembly, the shoulder belt spool pretensioner includes a shoulder belt pretensioner tube which conducts gas from the gas source wherein gas flowing in the shoulder belt pretensioner tube causes rotation of the shoulder belt spool for pretensioning the shoulder belt, and the lap belt spool pretensioner includes a lap belt spool pretensioner tube which conducts gas from the gas source wherein gas flowing in the lap belt pretensioner tube causes rotation of the lap belt spool for pretensioning the lap belt.
2. A seat belt retractor assembly in accordance with claim 1 further comprising a first plurality of balls positioned in the shoulder belt pretensioner tube which are forced to move in the shoulder belt pretensioner tube in response to the gas from the gas source to engage with a shoulder belt spool pretensioner sprocket to cause rotation of the shoulder belt spool for winding the shoulder belt spool and pretensioning the shoulder belt.
3. A seat belt retractor assembly in accordance with claim 1 further comprising a second plurality of balls positioned in the lap belt pretensioner tube which are forced to move in the lap belt pretensioner tube in response to the gas from the gas source to engage with a lap belt pretensioner sprocket to cause rotation of the lap belt spool for winding the lap belt spool and pretensioning the lap belt.
4. A seat belt retractor assembly in accordance with claim 1 wherein the shoulder belt further includes an inflatable belt section.
5. A seat belt retractor assembly in accordance with claim 1 wherein the seat belt retractor assembly is adapted to be mounted to a \u201cB\u201d pillar of the motor vehicle.
6. A seat belt retractor assembly in accordance with claim 1 wherein the retractor frame forms a slit through which the lap belt passes.
7. A seat belt retractor assembly in accordance with claim 1 wherein the shoulder belt spool assembly is affixed to the frame above the lap belt spool assembly.
8. A seat belt retractor assembly in accordance with claim 1 further comprising the gas source communicates with a common gas connection which communicates with both the shoulder belt pretensioner tube and the lap belt pretensioner tube.
9. A seat belt retractor assembly for a motor vehicle occupant restraint system of the type having a shoulder belt, a lap belt, and a latch plate between the shoulder and lap belts engageable with a buckle, the assembly comprising:
a retractor frame adapted to be mounted to the motor vehicle,
a shoulder belt spool assembly affixed to the frame and connected with the shoulder belt and having a rotatable shoulder belt spool with the shoulder belt wound on the shoulder belt spool for stowing and paying out the shoulder belt,
a lap belt spool assembly affixed to the frame and connected with the lap belt and having a rotatable lap belt spool with the lap belt wound on the lap belt spool for stowing and paying out the lap belt, and
a pretensioner unit having a single gas source communicating with and supplying gas to a shoulder belt pretensioner tube and a lap belt pretensioner tube, a first plurality of balls positioned in the shoulder belt pretensioner tube which are forced to move in the shoulder belt pretensioner tube in response to the gas from the gas source to engage with a shoulder belt spool pretensioner sprocket to cause rotation of the shoulder belt spool for winding the shoulder belt spool and pretensioning the shoulder belt, and a second plurality of balls positioned in the lap belt pretensioner tube which are forced to move in the lap belt pretensioner tube in response to the gas from the gas source to engage with a lap belt pretensioner sprocket to cause rotation of the lap belt spool for winding the lap belt spool and pretensioning the lap belt.
10. A seat belt retractor assembly in accordance with claim 9 wherein the shoulder belt further includes an inflatable belt section.
11. A seat belt retractor assembly in accordance with claim 9 wherein the seat belt retractor assembly is adapted to be mounted to a \u201cB\u201d pillar of the motor vehicle.
12. A seat belt retractor assembly in accordance with claim 9 wherein the retractor frame forms a slit through which the lower lap belt passes.
13. A seat belt retractor assembly in accordance with claim 9 wherein the shoulder belt spool assembly is affixed to the frame above the lap belt spool assembly.
14. A seat belt retractor assembly in accordance with claim 9 further comprising the gas source communicates with a common gas connection which communicates with both the shoulder belt pretensioner tube and the lap belt pretensioner tube.